Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Foveal Abnormality associated with epiretinal Tissue of medium reflectivity and Increased blue-light fundus Autofluorescence Signal (FATIAS).

dell'Omo R, De Turris S, Costagliola C, Virgili G, Schumann RG, Cereda M, D'Agostino I, dell'Omo E, Bottoni F.

Graefes Arch Clin Exp Ophthalmol. 2019 Sep 7. doi: 10.1007/s00417-019-04451-7. [Epub ahead of print]

PMID:
31494709
2.

The role of Müller cells in tractional macular disorders: an optical coherence tomography study and physical model of mechanical force transmission.

Govetto A, Hubschman JP, Sarraf D, Figueroa MS, Bottoni F, dell'Omo R, Curcio CA, Seidenari P, Delledonne G, Gunzenhauser R, Ferrara M, Au A, Virgili G, Scialdone A, Repetto R, Romano MR.

Br J Ophthalmol. 2019 Jul 20. pii: bjophthalmol-2019-314245. doi: 10.1136/bjophthalmol-2019-314245. [Epub ahead of print]

PMID:
31326893
3.

Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration.

Parmeggiani F, Gallenga CE, Costagliola C, Semeraro F, Romano MR, Dell'Omo R, Russo A, De Nadai K, Gemmati D, D'Angelo S, Bolletta E, Sorrentino FS.

Sci Rep. 2019 Feb 22;9(1):2614. doi: 10.1038/s41598-019-38919-7.

4.

The Relationship Between Blue-Fundus Autofluorescence and Optical Coherence Tomography in Eyes With Lamellar Macular Holes.

dell'Omo R, Vogt D, Schumann RG, De Turris S, Virgili G, Staurenghi G, Cereda M, Costagliola C, Priglinger SG, Bottoni F.

Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):3079-3087. doi: 10.1167/iovs.18-24379.

PMID:
30025144
5.

Confocal microscopy of corneal nerve plexus as an early marker of eye involvement in patients with type 2 diabetes.

dell'Omo R, Cifariello F, De Turris S, Romano V, Di Renzo F, Di Taranto D, Coclite G, Agnifili L, Mastropasqua L, Costagliola C.

Diabetes Res Clin Pract. 2018 Aug;142:393-400. doi: 10.1016/j.diabres.2018.06.010. Epub 2018 Jun 21.

PMID:
29935212
6.

Lamellar macular holes in the eyes with pathological myopia.

dell'Omo R, Virgili G, Bottoni F, Parolini B, De Turris S, Di Salvatore A, dell'Omo E, Costagliola C.

Graefes Arch Clin Exp Ophthalmol. 2018 Jul;256(7):1281-1290. doi: 10.1007/s00417-018-3995-8. Epub 2018 May 3.

PMID:
29725825
7.

Visualization of Lamellar Hole-Associated Epiretinal Proliferation With Blue-Reflectance Imaging.

dellʼOmo R, De Turris S, dellʼOmo E, Costagliola C.

Retina. 2018 May;38(5):e34-e35. doi: 10.1097/IAE.0000000000002048. No abstract available.

PMID:
29370037
8.

ILM peeling in nontractional diabetic macular edema: review and metanalysis.

Rinaldi M, dell'Omo R, Morescalchi F, Semeraro F, Gambicorti E, Cacciatore F, Chiosi F, Costagliola C.

Int Ophthalmol. 2018 Dec;38(6):2709-2714. doi: 10.1007/s10792-017-0761-6. Epub 2017 Oct 31. Review.

PMID:
29090356
9.

Incidence and Factors Influencing Retinal Displacement in Eyes Treated for Rhegmatogenous Retinal Detachment With Vitrectomy and Gas or Silicone Oil.

dell'Omo R, Scupola A, Viggiano D, Sammarco MG, De Turris S, Romano MR, Grimaldi G, dell'Omo E, Costagliola C.

Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO191-BIO199. doi: 10.1167/iovs.17-21466.

PMID:
28715581
10.

Role of Lamellar Hole-Associated Epiretinal Proliferation in Lamellar Macular Holes.

dell'Omo R, Virgili G, Rizzo S, De Turris S, Coclite G, Giorgio D, dell'Omo E, Costagliola C.

Am J Ophthalmol. 2017 Mar;175:16-29. doi: 10.1016/j.ajo.2016.11.007. Epub 2016 Nov 24.

PMID:
27889502
11.

Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia.

Rinaldi M, Semeraro F, Chiosi F, Russo A, Romano MR, Savastano MC, dell'Omo R, Costagliola C.

Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):529-539. doi: 10.1007/s00417-016-3498-4. Epub 2016 Sep 28.

PMID:
27680013
12.

Multimodal Imaging in Ophthalmology.

Toto L, dell'Omo R, Tosi GM, Querques G, Zweifel SA, Labbé A.

J Ophthalmol. 2016;2016:3120129. doi: 10.1155/2016/3120129. Epub 2016 Aug 10. No abstract available.

13.

Iatrogenic retinal breaks in ultrahigh-speed 25-gauge vitrectomy: a prospective study of elective cases.

Mura M, Barca F, Dell'Omo R, Nasini F, Peiretti E.

Br J Ophthalmol. 2016 Oct;100(10):1383-7. doi: 10.1136/bjophthalmol-2015-307654. Epub 2015 Dec 23.

PMID:
26701688
14.

Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration.

Parmeggiani F, Costagliola C, Semeraro F, Romano MR, Rinaldi M, Gallenga CE, Serino ML, Incorvaia C, D'Angelo S, De Nadai K, Dell'Omo R, Russo A, Gemmati D, Perri P.

Int J Mol Sci. 2015 Aug 20;16(8):19796-811. doi: 10.3390/ijms160819796.

15.

Diabetic Retinopathy: Vascular and Inflammatory Disease.

Semeraro F, Cancarini A, dell'Omo R, Rezzola S, Romano MR, Costagliola C.

J Diabetes Res. 2015;2015:582060. doi: 10.1155/2015/582060. Epub 2015 Jun 7. Review.

16.

Multimodal Approach to Monitoring and Investigating Cone Structure and Function in an Inherited Macular Dystrophy.

Ziccardi L, Giannini D, Lombardo G, Serrao S, Dell'Omo R, Nicoletti A, Bertelli M, Lombardo M.

Am J Ophthalmol. 2015 Aug;160(2):301-312.e6. doi: 10.1016/j.ajo.2015.04.024. Epub 2015 Apr 20.

PMID:
25908487
17.

Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation.

Costagliola C, Semeraro F, dell'Omo R, Romano MR, Russo A, Aceto F, Mastropasqua R, Porcellini A.

Br J Ophthalmol. 2015 Jul;99(7):1004-8. doi: 10.1136/bjophthalmol-2014-306465. Epub 2015 Mar 13.

PMID:
25770144
18.

Restoration of foveal thickness and architecture after macula-off retinal detachment repair.

dell'Omo R, Viggiano D, Giorgio D, Filippelli M, Di Iorio R, Calo' R, Cardone M, Rinaldi M, dell'Omo E, Costagliola C.

Invest Ophthalmol Vis Sci. 2015 Jan 22;56(2):1040-50. doi: 10.1167/iovs.14-15633.

PMID:
25613940
19.

Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy.

Cancarini A, Costagliola C, Dell'omo R, Romano M, Morescalchi F, Agnifili L, Ruggeri G, Semeraro F.

Minerva Endocrinol. 2014 Dec;39(4):305-11.

PMID:
25371057
20.

Some physicochemical remarks on spontaneous emulsification of vitreal tamponades.

Costagliola C, Semeraro F, dell'Omo R, Zeppa L, Bufalo G, Cardone M, Romano M, Ambrosone L.

Biomed Res Int. 2014;2014:243056. doi: 10.1155/2014/243056. Epub 2014 Jul 15. Review.

21.

Metamorphopsia and optical coherence tomography findings after rhegmatogenous retinal detachment surgery.

dell'Omo R, Mura M.

Am J Ophthalmol. 2014 Jun;157(6):1322-3. doi: 10.1016/j.ajo.2014.02.024. No abstract available.

PMID:
24881837
22.

Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy.

Semeraro F, Cancarini A, Morescalchi F, Romano MR, dell'Omo R, Ruggeri G, Agnifili L, Costagliola C.

Diabetes Metab. 2014 Dec;40(6):445-51. doi: 10.1016/j.diabet.2014.04.005. Epub 2014 May 27.

PMID:
24878492
23.

Effect of palmitoylethanolamide on visual field damage progression in normal tension glaucoma patients: results of an open-label six-month follow-up.

Costagliola C, Romano MR, dell'Omo R, Russo A, Mastropasqua R, Semeraro F.

J Med Food. 2014 Sep;17(9):949-54. doi: 10.1089/jmf.2013.0165. Epub 2014 May 14.

PMID:
24827384
24.

Risk of reactivation of toxoplasmic retinitis following intraocular procedures without the use of prophylactic therapy.

Heringer GC, Oueghlani E, Dell'Omo R, Curi AL, Oréfice F, Pavésio CE.

Br J Ophthalmol. 2014 Sep;98(9):1218-20. doi: 10.1136/bjophthalmol-2013-304259. Epub 2014 May 12.

PMID:
24820044
25.

Short-time prone posturing is well-tolerated and reduces the rate of unintentional retinal displacement in elderly patients operated on for retinal detachment.

dell'Omo R, Semeraro F, Guerra G, Verolino M, Cinelli M, Montagnani S, Costagliola C.

BMC Surg. 2013;13 Suppl 2:S55. doi: 10.1186/1471-2482-13-S2-S55. Epub 2013 Oct 8.

26.

TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy.

Costagliola C, Romano V, De Tollis M, Aceto F, dell'Omo R, Romano MR, Pedicino C, Semeraro F.

Mediators Inflamm. 2013;2013:629529. doi: 10.1155/2013/629529. Epub 2013 Oct 23.

27.

Topical nonsteroidal anti-inflammatory drugs for macular edema.

Russo A, Costagliola C, Delcassi L, Parmeggiani F, Romano MR, Dell'Omo R, Semeraro F.

Mediators Inflamm. 2013;2013:476525. doi: 10.1155/2013/476525. Epub 2013 Oct 21. Review.

28.

Influence of retinal vessel printings on metamorphopsia and retinal architectural abnormalities in eyes with idiopathic macular epiretinal membrane.

Dell'omo R, Cifariello F, Dell'omo E, De Lena A, Di Iorio R, Filippelli M, Costagliola C.

Invest Ophthalmol Vis Sci. 2013 Nov 21;54(12):7803-11. doi: 10.1167/iovs.13-12817.

PMID:
24204051
29.

Myopia onset and progression: can it be prevented?

Russo A, Semeraro F, Romano MR, Mastropasqua R, Dell'Omo R, Costagliola C.

Int Ophthalmol. 2014 Jun;34(3):693-705. doi: 10.1007/s10792-013-9844-1. Epub 2013 Sep 17. Review.

PMID:
24043334
30.

Aqueous humor levels of vascular endothelial growth factor and adiponectin in patients with type 2 diabetes before and after intravitreal bevacizumab injection.

Costagliola C, Daniele A, dell'Omo R, Romano MR, Aceto F, Agnifili L, Semeraro F, Porcellini A.

Exp Eye Res. 2013 May;110:50-4. doi: 10.1016/j.exer.2013.02.004. Epub 2013 Feb 20.

PMID:
23454098
31.

Vitreous mediators in retinal hypoxic diseases.

dell'Omo R, Semeraro F, Bamonte G, Cifariello F, Romano MR, Costagliola C.

Mediators Inflamm. 2013;2013:935301. doi: 10.1155/2013/935301. Epub 2013 Jan 10. Review.

32.

Evolution of outer retinal folds occurring after vitrectomy for retinal detachment repair.

dell'Omo R, Tan HS, Schlingemann RO, Bijl HM, Lesnik Oberstein SY, Barca F, Mura M.

Invest Ophthalmol Vis Sci. 2012 Dec 3;53(13):7928-35. doi: 10.1167/iovs.12-10322.

PMID:
23099492
33.

Longitudinal study of macular folds by spectral-domain optical coherence tomography.

dell'Omo R, Costagliola C.

Am J Ophthalmol. 2012 Oct;154(4):757-8; author reply 758-9. doi: 10.1016/j.ajo.2012.06.013. No abstract available.

PMID:
22995560
34.

Intravitreal pegaptanib sodium (Macugen) for treatment of myopic choroidal neovascularization: a morphologic and functional study.

Rinaldi M, Chiosi F, DellʼOmo R, Romano MR, Parmeggiani F, Semeraro F, Menzione M, Costagliola C.

Retina. 2013 Feb;33(2):397-402. doi: 10.1097/IAE.0b013e318261a73c.

PMID:
22990315
35.

Multiple evanescent white dot syndrome (MEWDS).

dell'Omo R, Pavesio CE.

Int Ophthalmol Clin. 2012 Fall;52(4):221-8. doi: 10.1097/IIO.0b013e31826647ed. Review. No abstract available.

PMID:
22954944
36.

Pars plana vitrectomy for the repair of primary, inferior rhegmatogenous retinal detachment associated to inferior breaks. A comparison of a 25-gauge versus a 20-gauge system.

Dell'Omo R, Barca F, Tan HS, Bijl HM, Oberstein SY, Mura M.

Graefes Arch Clin Exp Ophthalmol. 2013 Feb;251(2):485-90. doi: 10.1007/s00417-012-2059-8. Epub 2012 May 17.

37.

Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: a morphologic and functional study.

Rinaldi M, Chiosi F, dell'Omo R, Romano MR, Parmeggiani F, Semeraro F, Mastropasqua R, Costagliola C.

Br J Clin Pharmacol. 2012 Dec;74(6):940-6. doi: 10.1111/j.1365-2125.2012.04291.x.

38.

Early simultaneous fundus autofluorescence and optical coherence tomography features after pars plana vitrectomy for primary rhegmatogenous retinal detachment.

Dell'Omo R, Mura M, Lesnik Oberstein SY, Bijl H, Tan HS.

Retina. 2012 Apr;32(4):719-28. doi: 10.1097/IAE.0b013e31822c293e.

PMID:
22277926
39.

Silicone oil removal after rhegmatogenous retinal detachment: comparing techniques.

Tan HS, Dell'omo R, Mura M.

Eye (Lond). 2012 Mar;26(3):444-7. doi: 10.1038/eye.2011.319. Epub 2011 Dec 9.

40.

Aqueous humor levels of vascular endothelial growth factor before and after intravitreal bevacizumab in type 3 versus type 1 and 2 neovascularization. A prospective, case-control study.

dell'Omo R, Cassetta M, dell'Omo E, di Salvatore A, Hughes JM, Aceto F, Porcellini A, Costagliola C.

Am J Ophthalmol. 2012 Jan;153(1):155-61.e2. doi: 10.1016/j.ajo.2011.06.001. Epub 2011 Aug 20.

PMID:
21861975
41.

Acute juvenile cataract in newly diagnosed type 1 diabetic patients: a description of six cases.

Iafusco D, Prisco F, Romano MR, Dell'omo R, Libondi T, Costagliola C.

Pediatr Diabetes. 2011 Nov;12(7):642-8. doi: 10.1111/j.1399-5448.2010.00749.x. Epub 2011 Apr 7.

PMID:
21477105
42.

Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.

Kotecha A, Spratt A, Ogunbowale L, dell'Omo R, Kulkarni A, Bunce C, Franks WA.

Arch Ophthalmol. 2011 Feb;129(2):145-50. doi: 10.1001/archophthalmol.2010.350.

PMID:
21320957
43.

Foveal hypoautofluorescence: does it correlate to visual acuity in white dot syndromes?

dell'Omo R, Polisena P, dell'Omo E, Costagliola C.

Arch Ophthalmol. 2010 Dec;128(12):1628-9; author reply 1629-30. doi: 10.1001/archophthalmol.2010.278. No abstract available.

PMID:
21149795
44.

Age related macular degeneration and visual disability.

Christoforidis JB, Tecce N, Dell'Omo R, Mastropasqua R, Verolino M, Costagliola C.

Curr Drug Targets. 2011 Feb;12(2):221-33.

PMID:
20887239
45.

Natural evolution of fundus autofluorescence findings in multiple evanescent white dot syndrome: a long-term follow-up.

Dell'Omo R, Mantovani A, Wong R, Konstantopoulou K, Kulwant S, Pavesio CE.

Retina. 2010 Oct;30(9):1479-87. doi: 10.1097/IAE.0b013e3181d50cd3.

PMID:
20588204
46.

Enhanced depth imaging spectral-domain optical coherence tomography.

Dell'Omo R, Costagliola C, Di Salvatore F, Cifariello F, Dell'Omo E.

Retina. 2010 Feb;30(2):378-9. doi: 10.1097/IAE.0b013e3181c771eb. No abstract available.

PMID:
20142717
47.

Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration.

Costagliola C, Romano MR, Rinaldi M, dell'Omo R, Chiosi F, Menzione M, Semeraro F.

Br J Ophthalmol. 2010 Feb;94(2):180-4. doi: 10.1136/bjo.2009.159343. Epub 2009 Dec 3.

PMID:
19965822
48.

Pharmacotherapy of intraocular pressure - part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides.

Costagliola C, dell'Omo R, Romano MR, Rinaldi M, Zeppa L, Parmeggiani F.

Expert Opin Pharmacother. 2009 Dec;10(17):2859-70. doi: 10.1517/14656560903300129. Review.

PMID:
19929706
49.

Epiretinal membrane in a 12-year-old immunocompetent girl with cytomegalovirus infection.

Costagliola C, Romano MR, Parmeggiani F, Dell'omo R, Cultrera R.

Eur J Ophthalmol. 2009 Nov-Dec;19(6):1098-101.

PMID:
19882555
50.

Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics.

Costagliola C, dell'Omo R, Romano MR, Rinaldi M, Zeppa L, Parmeggiani F.

Expert Opin Pharmacother. 2009 Nov;10(16):2663-77. doi: 10.1517/14656560903300103. Review.

PMID:
19874249

Supplemental Content

Loading ...
Support Center